- Investing Ideas
- Swedish Pharmaceuticals & Biotech High Insider Buying
Swedish Pharmaceuticals & Biotech High Insider Buying
Results
12
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
12 companies
Swedish Orphan Biovitrum
Market Cap: SEK 148.0b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 427.80
7D
6.8%
1Y
46.0%
Camurus
Market Cap: SEK 31.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 531.00
7D
-5.3%
1Y
-14.5%
AddLife
Market Cap: SEK 17.4b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 142.90
7D
-13.5%
1Y
-21.9%
MedCap
Market Cap: SEK 7.2b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.
MCAP
SEK 479.80
7D
-2.9%
1Y
10.3%
Swedencare
Market Cap: SEK 4.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 26.90
7D
0%
1Y
-30.3%
Devyser Diagnostics
Market Cap: SEK 1.6b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 94.00
7D
6.8%
1Y
-7.8%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.40
7D
-4.4%
1Y
-18.5%
Corline Biomedical
Market Cap: SEK 411.1m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 16.05
7D
1.9%
1Y
50.7%
Mendus
Market Cap: SEK 314.7m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.13
7D
4.3%
1Y
1.6%
Promimic
Market Cap: SEK 213.5m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 11.30
7D
4.6%
1Y
-53.3%
Alzinova
Market Cap: SEK 68.6m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.44
7D
-7.8%
1Y
-77.7%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%